NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 18, 2025 $39.52 -1.27% $42.09 X 93.90% 0
Aug 18, 2025 Bullish $42.09 V 1
Aug 11, 2025 $37.39 -1.32% $38.19 X 97.90% 0
ngbots ngbots Merchant
Aug 11, 2025 Bullish $38.19 V 1
Jul 23, 2025 $31.48 -1.94% $33.40 X 94.25% 0
Jul 23, 2025 $31.71 -1.21% $33.40 X 94.94% 0
Jul 23, 2025 Bullish $33.40 V 1
Jul 14, 2025 $30.69 -1.34% $31.63 X 97.04% 0
Jul 14, 2025 Bullish $31.63 V 1
Jun 10, 2025 $26.95 -2.25% $29.14 X 92.49% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE